Metastatic Neuroendocrine Tumor in the Thyroid: Report of an Incidental Diagnosis

Uzma Mohammad Siddiqui, Aida L. Valencia-Guerrero, Nina Rosano, Eyad Hamoudeh

Abstract


Secondary tumors of the thyroid are quite rare with an estimated prevalence of < 1%. Herein, we describe the incidental discovery of metastatic small cell lung cancer in a non-toxic multinodular goiter. A 57-year-old lady has had a non-toxic multinodular goiter for over 10 years. She has had two thyroid fine needle aspirations (FNAs) in the past, which were reported benign. As the goiter was increasing in size and causing compression, she underwent a total thyroidectomy. Pathology revealed multi-centric high grade carcinoma with small cell/neuroendocrine features with the largest focus being 1.1 cm. Calcitonin staining was negative. Further imaging revealed a 68 × 37 × 51 mm soft tissue mediastinal mass and an 18 × 10 mm left upper lobe pulmonary nodule. She was then initiated on chemotherapy and radiation therapy for extensive stage small cell cancer of the lung. After two cycles of chemotherapy, restaging chest computed tomography (CT) showed interval improvement in lung masses. This rare presentation of small cell lung cancer with multi-centric metastasis to the thyroid highlights the need to obtain nodule directed FNAs, as the two non-directed FNAs done prior to surgery were benign. It also points out to clinicians that rapidly growing goiters are a cause for concern, and should be evaluated, even if patients are not symptomatic.




J Endocrinol Metab. 2017;7(6):190-193
doi: https://doi.org/10.14740/jem468w


Keywords


Thyroid; Neuroendocrine; Metastatic; Goiter

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

DECLARATION: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!